LUNG
Pulmonx Corp.
NASDAQ · Healthcare · Medical - Devices · US
$2.83
+4.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.60x
- Price / sales
- 1.39x
- Price / cash flow
- -4.82x
Enterprise value
- Enterprise value
- $126.9M
- EV / sales
- 1.43x
- EV / EBITDA
- -3.44x
- EV / EBIT
- -3.22x
- Market cap
- $123.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026